Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia.
作者信息
Kasthuri Raj S, Montifar Megan, Nelson Jeffrey, Kim Helen, Lawton Michael T, Faughnan Marie E
机构信息
Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Division of Respirology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Canada.
出版信息
Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
Abstract
摘要
相似文献
1
Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症贫血的患病率及预测因素
Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
2
Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C.慢性丙型肝炎长期α干扰素治疗使遗传性出血性毛细血管扩张症及贫血得到缓解
J Clin Gastroenterol. 2004 Apr;38(4):377-9. doi: 10.1097/00004836-200404000-00015.
3
Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia.遗传性出血性毛细血管扩张症：严重贫血的罕见病因。
J Bras Pneumol. 2007 Jan-Feb;33(1):109-12. doi: 10.1590/s1806-37132007000100020.
4
Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.遗传性出血性毛细血管扩张症相关肺动脉高压伴 ACVRL1 突变：病例报告。
J Med Case Rep. 2022 Mar 1;16(1):99. doi: 10.1186/s13256-022-03296-9.
5
Management of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia: a cohort from a single academic center's experience.遗传性出血性毛细血管扩张症患者行全身麻醉的管理：单中心经验的队列研究。
J Anesth. 2013 Oct;27(5):705-11. doi: 10.1007/s00540-013-1601-0. Epub 2013 Apr 5.
6
The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.遗传性出血性毛细血管扩张症在青少年息肉综合征中的患病率。
Dis Colon Rectum. 2012 Aug;55(8):886-92. doi: 10.1097/DCR.0b013e31825aad32.
7
Prevalence of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia: Report from a Single Reference Center.遗传性出血性毛细血管扩张症患者颅内动脉瘤的患病率：来自单一参考中心的报告。
AJNR Am J Neuroradiol. 2022 Jun;43(6):844-849. doi: 10.3174/ajnr.A7505. Epub 2022 May 19.
8
Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years.遗传性出血性毛细血管扩张症的神经血管表现：15年间376例连续病例系列
AJNR Am J Neuroradiol. 2016 Aug;37(8):1479-86. doi: 10.3174/ajnr.A4762. Epub 2016 Mar 24.
9
Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者颅内动脉瘤的患病率及特征。
AJNR Am J Neuroradiol. 2023 Dec 11;44(12):1367-1372. doi: 10.3174/ajnr.A8058.
10
Basal Ganglia T1 Hyperintensity in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症的基底节 T1 高信号。
AJNR Am J Neuroradiol. 2017 Oct;38(10):1929-1933. doi: 10.3174/ajnr.A5322. Epub 2017 Aug 3.
引用本文的文献
1
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.遗传性出血性毛细血管扩张症出血的术语、定义和结局标准的标准化：国际共识报告
Am J Hematol. 2025 Oct;100(10):1813-1827. doi: 10.1002/ajh.70011. Epub 2025 Jul 15.
2
Genotype-Phenotype Relationship in Hereditary Hemorrhagic Telangiectasia: Quality of Life and Cardiovascular Risk Evaluation.遗传性出血性毛细血管扩张症的基因型-表型关系：生活质量与心血管风险评估
J Clin Med. 2025 Jun 20;14(13):4409. doi: 10.3390/jcm14134409.
3
Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症的医疗利用情况及成本特征分析
Am J Hematol. 2025 Jul 2. doi: 10.1002/ajh.27756.
4
Quantifying the burden of hereditary hemorrhagic telangiectasia on quality of life and psychological health: a cross-sectional study.量化遗传性出血性毛细血管扩张症对生活质量和心理健康的影响：一项横断面研究。
Orphanet J Rare Dis. 2025 Mar 7;20(1):109. doi: 10.1186/s13023-025-03620-8.
5
Potential and emerging therapeutics for HHT.遗传性出血性毛细血管扩张症的潜在及新兴治疗方法
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):724-727. doi: 10.1182/hematology.2024000675.
6
The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review.沙利度胺及其类似物在遗传性出血性毛细血管扩张症治疗中的作用：一项系统评价
J Clin Med. 2024 Sep 12;13(18):5404. doi: 10.3390/jcm13185404.
7
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.泊马度胺治疗遗传性出血性毛细血管扩张症鼻出血。
N Engl J Med. 2024 Sep 19;391(11):1015-1027. doi: 10.1056/NEJMoa2312749.
8
Evaluation of AAV Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy.用于遗传性出血性毛细血管扩张症基因治疗的腺相关病毒衣壳及递送方法的评估
Transl Stroke Res. 2025 Jun;16(3):914-924. doi: 10.1007/s12975-024-01275-4. Epub 2024 Jul 8.
9
Evaluation of Aav Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy.用于遗传性出血性毛细血管扩张症基因治疗的腺相关病毒衣壳和递送方法的评估
Res Sq. 2024 Jun 12:rs.3.rs-4469011. doi: 10.21203/rs.3.rs-4469011/v1.
10
How I treat bleeding in hereditary hemorrhagic telangiectasia.我如何治疗遗传性出血性毛细血管扩张症的出血。
Blood. 2024 Aug 29;144(9):940-954. doi: 10.1182/blood.2023021765.
本文引用的文献
1
A systematic analysis of global anemia burden from 1990 to 2010.1990 年至 2010 年全球贫血负担的系统分析。
Blood. 2014 Jan 30;123(5):615-24. doi: 10.1182/blood-2013-06-508325. Epub 2013 Dec 2.
2
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.国际遗传性出血性毛细血管扩张症诊断和管理指南。
J Med Genet. 2011 Feb;48(2):73-87. doi: 10.1136/jmg.2009.069013. Epub 2009 Jun 23.
3
Prevalence of iron deficiency and health-related quality of life among female students.女学生中铁缺乏症的患病率及与健康相关的生活质量
J Am Coll Nutr. 2008 Apr;27(2):337-41. doi: 10.1080/07315724.2008.10719709.
4
Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health.缺铁、总体健康状况与疲劳：澳大利亚女性健康纵向研究结果
Qual Life Res. 2000;9(5):491-7. doi: 10.1023/a:1008978114650.
5
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).遗传性出血性毛细血管扩张症（伦杜-奥斯勒-韦伯综合征）的诊断标准。
Am J Med Genet. 2000 Mar 6;91(1):66-7. doi: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p.
6
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients.遗传性出血性毛细血管扩张症：一项基于丹麦患者人群的患病率和死亡率研究。
J Intern Med. 1999 Jan;245(1):31-9. doi: 10.1046/j.1365-2796.1999.00398.x.
Zotero 插件